Seoul Pharma Co., Ltd

₩1,687As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:018680Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (16.02%)
Div yield 2.37%
ROE 4.39%
Pharmaceutical Preparations
Beta (5Y) 0.47
PE TTM 11.31
TSR TTM (45.23%)
Mkt cap ₩19.67B
ROIC (1.98%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩2,010
19.18%
(83.75%)
Hold 7|12|11|1|7
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
19.11
20.67
20.24
19.85
12.26%
25.45%
19.72%
9.23%
Revenue₩B
1.165
1.205
1.185
1.153
14.97%
12.89%
7.21%
(1.56%)
Peers (US$14.50M)
Cap (US$)
PE
14.32M
10.49x
Capital
TTM
5Y
10Y
Leveragex
1.357
(0.381)
(0.341)
EBIT/Intx
0.987
0.336
0.317
Own earn%
274.91
4.20
3.63
Sh yield%
49.30
23.76
23.65
Owners
Insiders/Inst%
8.34
25.65
Short interest%
1.95
SBC / revenue%
4.11
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
8–12
$1 testx
0.0
Incr. ROIC%
9